InvestorsHub Logo
Followers 30
Posts 2777
Boards Moderated 3
Alias Born 10/24/2015

Re: None

Thursday, 09/29/2022 2:09:03 PM

Thursday, September 29, 2022 2:09:03 PM

Post# of 376
(OT) A report on two patients with chemotherapy resistant metastatic sarcoma patients who were treated with an autologous NK cell therapy, and Keytruda https://www.auctoresonline.org/article/durable-responses-using-snk01-autologous-enhanced-natural-killer-cells-and-pembrolizumab-for-chemotherapy-resistant-advanced-sarcoma-case-reports-review-of-literature--and-future-perspectives
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent FATE News